Patent · US Active

Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)

US10570194B2 · kind B2 · utility

1Cited by
6References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2016
Grant dateFeb 25, 2020
Priority date
Expiry dateMay 17, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods of the present invention prevent, inhibit or reduce the toxic effects of proteins and toxins secreted from microbes. A method for neutralizing microbial protein products in a subject comprises administering a composition to the subject, said composition comprising plasma-derived IgM and optionally one or more excipients in a pharmaceutical carrier, wherein the composition is administered in an amount effective to neutralize the microbial protein products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.